
News|Articles|September 1, 2007
Drug Watch: Agents in late-stage development for the treatment of allergic rhinitis and sinusitis/rhinosinusitis (September 2007) (PDF)
Agents in late-stage development for the treatment of allergic rhinitis and sinusitis/rhinosinusitis
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
FDA issues third rejection of bevacizumab to treat wet AMD
2
Predictions for 2026 from Lucille Accetta, RPh, M.P.H., MBA, A.J. Loiacono and Allan Pannier, Pharm.D. MBA
3
Predictions for 2026 from Marci Chodroff, M.D., Jeffrey Casberg, RPh, M.S., and others
4
Top 5 articles from the MHE print publication in 2025
5




















































